152 related articles for article (PubMed ID: 17640790)
1. A monoamine oxidase B gene variant and short-term antidepressant treatment response.
Tadić A; Rujescu D; Müller MJ; Kohnen R; Stassen HH; Dahmen N; Szegedi A
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Oct; 31(7):1370-7. PubMed ID: 17640790
[TBL] [Abstract][Full Text] [Related]
2. The MAOA T941G polymorphism and short-term treatment response to mirtazapine and paroxetine in major depression.
Tadić A; Müller MJ; Rujescu D; Kohnen R; Stassen HH; Dahmen N; Szegedi A
Am J Med Genet B Neuropsychiatr Genet; 2007 Apr; 144B(3):325-31. PubMed ID: 17192957
[TBL] [Abstract][Full Text] [Related]
3. Effects of the serotonin transporter gene promoter polymorphism on mirtazapine and paroxetine efficacy and adverse events in geriatric major depression.
Murphy GM; Hollander SB; Rodrigues HE; Kremer C; Schatzberg AF
Arch Gen Psychiatry; 2004 Nov; 61(11):1163-9. PubMed ID: 15520364
[TBL] [Abstract][Full Text] [Related]
4. MAOA gene polymorphisms and response to mirtazapine in major depression.
Tzeng DS; Chien CC; Lung FW; Yang CY
Hum Psychopharmacol; 2009 Jun; 24(4):293-300. PubMed ID: 19382113
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of mirtazapine as add-on to paroxetine
Xiao L; Zhu X; Gillespie A; Feng Y; Zhou J; Chen X; Gao Y; Wang X; Ma X; Gao C; Xie Y; Pan X; Bai Y; Xu X; Wang G; Chen R
Psychol Med; 2021 May; 51(7):1166-1174. PubMed ID: 31931894
[TBL] [Abstract][Full Text] [Related]
6. Early improvement under mirtazapine and paroxetine predicts later stable response and remission with high sensitivity in patients with major depression.
Szegedi A; Müller MJ; Anghelescu I; Klawe C; Kohnen R; Benkert O
J Clin Psychiatry; 2003 Apr; 64(4):413-20. PubMed ID: 12716243
[TBL] [Abstract][Full Text] [Related]
7. Remission with mirtazapine and selective serotonin reuptake inhibitors: a meta-analysis of individual patient data from 15 controlled trials of acute phase treatment of major depression.
Thase ME; Nierenberg AA; Vrijland P; van Oers HJ; Schutte AJ; Simmons JH
Int Clin Psychopharmacol; 2010 Jul; 25(4):189-98. PubMed ID: 20531012
[TBL] [Abstract][Full Text] [Related]
8. The catechol-O-methyltransferase Val108/158Met polymorphism affects short-term treatment response to mirtazapine, but not to paroxetine in major depression.
Szegedi A; Rujescu D; Tadic A; Müller MJ; Kohnen R; Stassen HH; Dahmen N
Pharmacogenomics J; 2005; 5(1):49-53. PubMed ID: 15520843
[TBL] [Abstract][Full Text] [Related]
9. Comparisons of the efficacy and tolerability of extended-release venlafaxine, mirtazapine, and paroxetine in treatment-resistant depression: a double-blind, randomized pilot study in a Chinese population.
Fang Y; Yuan C; Xu Y; Chen J; Wu Z; Cao L; Yi Z; Hong W; Wang Y; Jiang K; Gao K; Cui X; Nierenberg AA;
J Clin Psychopharmacol; 2010 Aug; 30(4):357-64. PubMed ID: 20571433
[TBL] [Abstract][Full Text] [Related]
10. An innovative design to establish proof of concept of the antidepressant effects of the NR2B subunit selective N-methyl-D-aspartate antagonist, CP-101,606, in patients with treatment-refractory major depressive disorder.
Preskorn SH; Baker B; Kolluri S; Menniti FS; Krams M; Landen JW
J Clin Psychopharmacol; 2008 Dec; 28(6):631-7. PubMed ID: 19011431
[TBL] [Abstract][Full Text] [Related]
11. Influence of monoamine oxidase A and serotonin receptor 2A polymorphisms in SSRI antidepressant activity.
Cusin C; Serretti A; Zanardi R; Lattuada E; Rossini D; Lilli R; Lorenzi C; Smeraldi E
Int J Neuropsychopharmacol; 2002 Mar; 5(1):27-35. PubMed ID: 12057029
[TBL] [Abstract][Full Text] [Related]
12. The apolipoprotein E epsilon4 allele and antidepressant efficacy in cognitively intact elderly depressed patients.
Murphy GM; Kremer C; Rodrigues H; Schatzberg AF;
Biol Psychiatry; 2003 Oct; 54(7):665-73. PubMed ID: 14512205
[TBL] [Abstract][Full Text] [Related]
13. Pharmacogenetics of antidepressant medication intolerance.
Murphy GM; Kremer C; Rodrigues HE; Schatzberg AF
Am J Psychiatry; 2003 Oct; 160(10):1830-5. PubMed ID: 14514498
[TBL] [Abstract][Full Text] [Related]
14. The impact of chronic depression on acute and long-term outcomes in a randomized trial comparing selective serotonin reuptake inhibitor monotherapy versus each of 2 different antidepressant medication combinations.
Sung SC; Haley CL; Wisniewski SR; Fava M; Nierenberg AA; Warden D; Morris DW; Kurian BT; Trivedi MH; Rush AJ;
J Clin Psychiatry; 2012 Jul; 73(7):967-76. PubMed ID: 22687487
[TBL] [Abstract][Full Text] [Related]
15. The cost-effectiveness of mirtazapine versus paroxetine in treating people with depression in primary care.
Romeo R; Patel A; Knapp M; Thomas C
Int Clin Psychopharmacol; 2004 May; 19(3):125-34. PubMed ID: 15107654
[TBL] [Abstract][Full Text] [Related]
16. Non response at week 4 as clinically useful indicator for antidepressant combination in major depressive disorder. A sequential RCT.
Kato M; Takekita Y; Koshikawa Y; Sakai S; Bandou H; Nishida K; Sunada N; Onohara A; Hatashita Y; Serretti A; Kinoshita T
J Psychiatr Res; 2017 Jun; 89():97-104. PubMed ID: 28213170
[TBL] [Abstract][Full Text] [Related]
17. Mirtazapine versus selective serotonin reuptake inhibitors.
Thompson C
J Clin Psychiatry; 1999; 60 Suppl 17():18-22; discussion 46-8. PubMed ID: 10446737
[TBL] [Abstract][Full Text] [Related]
18. Influence and interaction of genetic, cognitive, neuroendocrine and personalistic markers to antidepressant response in Chinese patients with major depression.
Bi Y; Ren D; Guo Z; Ma G; Xu F; Chen Z; An L; Zhang N; Ji L; Yuan F; Liu L; Hou B; Yang F; Yu S; Yi Z; Xu Y; He L; Sun X; Dong Z; Wu S; Zhao L; Cai C; Li X; Yu T; Shi Y; He G
Prog Neuropsychopharmacol Biol Psychiatry; 2021 Jan; 104():110036. PubMed ID: 32702381
[TBL] [Abstract][Full Text] [Related]
19. FKBP5 polymorphisms and antidepressant response in geriatric depression.
Sarginson JE; Lazzeroni LC; Ryan HS; Schatzberg AF; Murphy GM
Am J Med Genet B Neuropsychiatr Genet; 2010 Mar; 153B(2):554-560. PubMed ID: 19676097
[TBL] [Abstract][Full Text] [Related]
20. Association analysis between variants of the interleukin-1beta and the interleukin-1 receptor antagonist gene and antidepressant treatment response in major depression.
Tadić A; Rujescu D; Müller MJ; Kohnen R; Stassen HH; Szegedi A; Dahmen N
Neuropsychiatr Dis Treat; 2008 Feb; 4(1):269-76. PubMed ID: 18728809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
